Search Results - "Peglau, I."

Effective cabergoline treatment in idiopathic restless legs syndrome by STIASNY-KOLSTER, K, BENES, H, PEGLAU, I, HORNYAK, M, HOLINKA, B, WESSEL, K, EMSER, W, LEROUX, M, KOHNEN, R, OERTEL, W. H

“…To assess the efficacy and safety of the dopamine agonist cabergoline (CAB) in patients with restless legs syndrome (RLS). Patients with moderate to severe RLS…”
Get full text

Efficacy of cabergoline in restless legs syndrome : A placebo-controlled study with polysomnography (CATOR) by OERTEL, W. H, BENES, H, STIASNY-KOLSTER, K, BODENSCHATZ, R, PEGLAU, I, WARMUTH, R, HAPPE, S, GEISLER, P, CASSEL, W, LEROUX, M, KOHNEN, R

“…To assess the efficacy and safety of the dopamine agonist cabergoline in the treatment of patients with idiopathic restless legs syndrome (CATOR study)…”
Get full text

Epilepsy outcomes in elderly treated with topiramate by Stefan, H., Hubbertz, L., Peglau, I., Berrouschot, J., Kasper, B., Schreiner, A., Krimmer, J., Schauble, B.

“…Objectives –  To explore effectiveness, tolerability and quality of life in elderly patients with epilepsy treated with topiramate. Methods –  One year,…”
Get full text

Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment by Hornyak, M, Benes, H, Eisensehr, I, Haan, J, Kassubek, J, Peglau, I, Stiasny-Kolster, K, Trenkwalder, C

“…Depressive disorders are a prevalent comorbidity in restless legs syndrome (RLS). Although similar prevalence rates of comorbid depression can be found in…”
Get full text

The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study by Scherer, P., Penner, I.K., Rohr, A., Boldt, H., Ringel, I., Wilke-Burger, H., Burger-Deinerth, E., Isakowitsch, K., Zimmermann, M., Zahrnt, S., Hauser, R., Hilbert, K., Tiel-Wilck, K., Anvari, K., Behringer, A., Peglau, I., Friedrich, H., Plenio, A., Benesch, G., Ehret, R., Nippert, I., Finke, G., Schulz, I., Bergtholdt, B., Breitkopf, S., Kaskel, P., Reischies, F., Kugler, J.

“…Reliable, language-independent, short screening instruments to test for cognitive function in patients with multiple sclerosis (MS) remain rare, despite the…”
Get full text

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension by Oertel, Wolfgang H., Hallström, Yngve, Saletu-Zyhlarz, Gerda M., Hopp, Michael, Bosse, Björn, Trenkwalder, Claudia

“…Objective The aim was to assess the effects of prolonged release oxycodone/naloxone (OXN PR) on sleep and quality of life (QoL) in patients with severe…”
Get full text

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome by Trenkwalder, Claudia, Stiasny-Kolster, Karin, Kupsch, Andreas, Oertel, Wolfgang H., Koester, Juergen, Reess, Juergen

“…Although dopamine agonists are becoming first‐line therapy for restless legs syndrome (RLS), few reports describe treatment periods exceeding 12 weeks. Here,…”
Get full text

Depressive Erkrankungen beim Restless-legs-Syndrom: Pathogenese, Diagnose und Implikationen für die Therapie by Hornyak, M., Benes, H., Eisensehr, I., Haan, J., Kassubek, J., Peglau, I., Stiasny-Kolster, K., Trenkwalder, C.

“…Zusammenfassung Depressive Störungen sind eine häufige Komorbidität beim Restless-legs-Syndrom (RLS). Vergleichbare Prävalenzraten von Begleitdepressionen…”
Get full text

Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment by Hornyak, M, Benes, H, Eisensehr, I, Haan, J, Kassubek, J, Peglau, I, Stiasny-Kolster, K, Trenkwalder, C

Get full text

Restless legs syndrome. Guidelines for diagnosis and therapy by Benes, H, Hening, W, Högl, B, Peglau, I, Schüler, P, Stiasny, K, Trenkwalder, C, Voderholzer, U

Get more information